Treating hypertension – a new approach

Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians. Research has indicated that a new pharmacological...

Q&A: ‘I’m going overseas tomorrow . . . can you witness...

While pharmacists are now (very) familiar with rapid antigen tests (RATs) for COVID-19 testing, the practice of observed RATs for the purpose of international...

PSA’s projects make a bigger impact than ever before

The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.

Call for pharmacist access to the MBS for Chronic Disease Management

Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense. After a...

Why pharmacists should be embedded in healthcare teams

The Pharmaceutical Society of Australia’s (PSA) Pharmacists in 2023 report found that the inclusion of pharmacists in healthcare teams will ensure that medicines are used...

Harnessing different abilities

Some might assume employing someone with a declared disability would only bring complications. But some community pharmacies around Australia are leading the way in...